| scholarly article | Q13442814 |
| P50 | author | Roy A Mariuzza | Q115642108 |
| P2093 | author name string | Qian Wang | |
| Yili Li | |||
| P2860 | cites work | Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. | Q34542306 |
| CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics | Q34738334 | ||
| Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses. | Q35005893 | ||
| Immune functions encoded by the natural killer gene complex | Q35096191 | ||
| Cellular ligands of activating NK receptors. | Q36083531 | ||
| Surface NK receptors and their ligands on tumor cells | Q36490899 | ||
| Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors | Q36493811 | ||
| Activation, coactivation, and costimulation of resting human natural killer cells | Q36652166 | ||
| Line of attack: NK cell specificity and integration of signals | Q36930253 | ||
| Inhibitory B7-family molecules in the tumour microenvironment | Q37171804 | ||
| Formation and function of the lytic NK-cell immunological synapse | Q37378585 | ||
| The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. | Q37586853 | ||
| ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype | Q39903222 | ||
| Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. | Q51541351 | ||
| The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences. | Q53567361 | ||
| Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus | Q56956215 | ||
| Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors | Q22010160 | ||
| Structural basis for co-stimulation by the human CTLA-4/B7-2 complex | Q24291065 | ||
| Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses | Q24291066 | ||
| Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA | Q24291172 | ||
| HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53 | Q24301527 | ||
| The human natural killer cell immune synapse | Q24656137 | ||
| Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells | Q24671834 | ||
| Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 | ||
| PROCHECK: a program to check the stereochemical quality of protein structures | Q26778411 | ||
| Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
| Structure and dimerization of a soluble form of B7-1 | Q27621238 | ||
| Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand | Q27622806 | ||
| Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3 | Q27637067 | ||
| Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D | Q27637579 | ||
| Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands | Q27640897 | ||
| The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity | Q27641400 | ||
| Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors | Q27641970 | ||
| The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors | Q27649885 | ||
| Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2 | Q27651269 | ||
| Likelihood-enhanced fast rotation functions | Q27860684 | ||
| Shape complementarity at protein/protein interfaces | Q27860963 | ||
| XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density | Q27861034 | ||
| The atomic structure of protein-protein recognition sites | Q27861113 | ||
| The immunoglobulin superfamily--domains for cell surface recognition | Q28294978 | ||
| Symmetry Recognizing Asymmetry | Q29038396 | ||
| Up on the tightrope: natural killer cell activation and inhibition | Q29619175 | ||
| The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans | Q33292180 | ||
| Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells | Q33292289 | ||
| Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition | Q33867251 | ||
| Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. | Q34178128 | ||
| The immunological synapse. | Q34178149 | ||
| Roles of the NKG2D immunoreceptor and its ligands | Q34267094 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytotoxicity | Q246181 |
| P304 | page(s) | 703-714 | |
| P577 | publication date | 2011-03-21 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6. | |
| P478 | volume | 208 |
| Q91971683 | An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More |
| Q36787587 | An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo |
| Q38129635 | B7 family checkpoint regulators in immune regulation and disease |
| Q89093262 | B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex |
| Q34501622 | B7-H6 expression in non-small cell lung cancers. |
| Q35798978 | B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape |
| Q38769013 | B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells |
| Q47436657 | Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6. |
| Q37007501 | Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC. |
| Q35705068 | Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody |
| Q40082730 | Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status. |
| Q39134627 | Ganoderma lucidum stimulates NK cell cytotoxicity by inducing NKG2D/NCR activation and secretion of perforin and granulysin |
| Q37021079 | Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production |
| Q36544773 | HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity |
| Q39055067 | Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands |
| Q39396311 | Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. |
| Q40078923 | Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20. |
| Q36102137 | Human herpesviridae methods of natural killer cell evasion |
| Q37714642 | Human γδT-cell subsets and their involvement in tumor immunity. |
| Q36882792 | Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity |
| Q50234398 | Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida. |
| Q38676458 | NK cells and cancer: you can teach innate cells new tricks. |
| Q27014888 | NKG2D ligands as therapeutic targets |
| Q35737498 | NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure |
| Q38173692 | Natural cytotoxicity receptors and their ligands |
| Q36701917 | Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. |
| Q37124504 | Natural killer cells and their receptors in multiple sclerosis |
| Q93167071 | Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis |
| Q37678862 | Structural basis for recognition of cellular and viral ligands by NK cell receptors |
| Q38200088 | TLR/NCR/KIR: Which One to Use and When? |
| Q49956252 | Tailoring Natural Killer cell immunotherapy to the tumour microenvironment. |
| Q37995950 | Targeting natural killer cells and natural killer T cells in cancer |
| Q36841260 | Targeting the B7 family of co-stimulatory molecules: successes and challenges |
| Q48098708 | The B7 Family Member B7-H6: a New Bane of Tumor |
| Q37988965 | The B7 homologues and their receptors in hematologic malignancies. |
| Q64248384 | The Natural Cytotoxicity Receptors in Health and Disease |
| Q40501505 | The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex. |
| Q48239951 | The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma |
| Q38323488 | The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding |
| Q38006620 | Virus-mediated inhibition of natural cytotoxicity receptor recognition |
Search more.